Antonio Giordano, President of the Sbarro Health Research Organization, shared a post on LinkedIn:
“Our latest work, published in Experimental and Molecular Pathology, lays the foundation for future investigations, including the development of biomarkers, with potential implications for the diagnostic and prognostic assessment of MPM.”
More posts featuring Antonio Giordano.